Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:

Sunday, November 13, 2016

Effects of a single, oral 60 mg caffeine dose on attention in healthy adult subjects

Just maybe this might help survivors attend to cognitive tasks. But we will never know since we have NO stroke strategy to update or follow thru on. We have fools and jesters in stroke leadership. Don't expect anything to improve until the existing stroke associations are destroyed. Don't do this on your own.
Journal of Psychopharmacology, 10/07/2016
 Wilhelmus MMM, et al. – This study exhibited that in healthy adult subjects oral administration of a single 60 mg caffeine dose elicited a clear enhancement of sustained attention and alertness, measured both in multiple objective performances and in subjective scales.


  • In this study, the researchers investigated the acute impacts of a 60 mg dose of caffeine on sustained attention in tests lasting up to 45 minutes using 82 low or non-caffeine-consuming healthy male (n=41) and female (n=41) adults aged somewhere around 40 and 60 years.  
  •  Vigilance was measured utilizing Mackworth Clock test, Rapid Visual Information Processing Test, adaptive tracking test, saccadic eye movement and attention switch test.
  • Impacts on mood and fatigue were analysed utilizing Bond and Lader and Caffeine Research visual analogue scales, and Samn–Perelli questionnaire.
  • Saliva sampling was performed for both compliance and caffeine pharmacokinetic analysis.   


  • Researchers found that administration of a 60 mg caffeine dose brought about a significant improvement in sustained attention compared with the placebo.  
  • Additionally a significantly improved peak saccadic velocity and reaction time performance was found, and diminished error rate.  
  • Significantly expanded feelings of alertness, contentment and overall mood after caffeine treatment compared with placebo were watched.   
Go to PubMed Go to Abstract Print Article Summary Cat 2 CME Report

No comments:

Post a Comment